Discussing effective, novel technology and recent discoveries of translational neuroscience in London

5th Annual MarketsandMarkets Neuroscience R&D Technologies Conference

London, UK, June 20th, 2019 – 5th Annual MarketsandMarkets Neuroscience R&D Technologies Conference will be discussing the latest technologies in the preclinical, translational neuroscience space. The conference will take place on 3rd and 4th October 2019 in London, UK also brings attention to new innovations of translational neuroscience imaging.

This is a first ever conference focusing on applications of technology in developing neurological treatments where you will be able to meet global neuroscience heads from industry and academia. over the 2-days, 20+ industry leading speakers will be sharing their research & insights on CNS drug discovery, Latest optogenetic tools, Kinematic techniques, Blood-brain barrier proteomics and Non-invasive electrical brain stimulation.

Being in the 5th Annual, the conference will host 15+ solutions providers and 100+ professionals working on Neuroscience/CNS drug discovery, Translational Neuroscience, Pre-clinical research, Computational Neuroscience/Neuroinformatic, Neurotechnology, Neuroimaging /Translational Imaging, Neurodegenerative diseases, Neuroengineering, Neuropharmacology/Neurobiology, Neuromorphic engineers.

The conference will be covering topics such as:

  • The role of imaging biomarkers in CNS drug discovery
  • New techniques in Two Photon Microscopy and its application in Neuroscience
  • Role of biomarkers in treating neurodegenerative diseases
  • Closed loop stimulation in Parkinson’s disease
  • Trends in Connectomics for understanding the synaptic conditions

Silvia Cainarca from IMI2 project -NGN-PET will be presenting on ‘Human iPSC-derived cells: a powerful tool for neuropathic pain disease modelling’ and Mark Tricklebank from King’s College London, UK will be speaking about ‘Why is Pharma so scared of psychiatric drug discovery is the fear justified?’

Apart from Silvia and Mark, the event will see presentations from OxStem, Takeda, The Weizmann Institute of Science, Cerevance and the University of Bristol, University of Sheffield, Harvard University and Eli Lilly.

Psychogenics, Axol Bioscience and The Science Behind have already confirmed as conference sponsors who will also be showcasing their products and services. The conference is supported by renowned industry associations such as Biopartner UK, EuropaBio and NeuroModec along with media partners like PharmaVoice, PharmaTutor, SciDoc Publishers, Technology Networks, Mednous, and GEN Engineering.

The event overview, registration details, and complete speaker list are available on the official website. You can also download the complete agenda to identify the potential interest in the conference on this page – https://bit.ly/2GUGfZu or you can directly email on events@marketsandmarkets.com asking for more details, your queries and provide feedback.

Markets and Markets Conferences (MnM Conferences) produces global summits, congresses and conferences bringing together key industry experts from academia and industry, fostering the exchange of ideas and latest research through cutting edge conference programs, interactive panel and round table discussions. Conferences are currently held or planned in the UK, Europe, USA and across Asia.

Related posts

Leave a Comment